What do pregnancy data show about the risk of birth defects with doxylamine succinate and pyridoxine hydrochloride in Xonvea?

Extensive pregnancy data, including two meta-analyses covering over 168,000 patients and 18,000 first-trimester exposures, indicate no birth-defect or fetal/neonatal toxicity risk from doxylamine succinate and pyridoxine hydrochloride in Xonvea.